Serum ischemia-modified albumin concentration may reflect long-term hypoxia in chronic respiratory disease: a pilot study

Clin Chem Lab Med. 2018 Nov 27;56(12):e288-e290. doi: 10.1515/cclm-2018-0150.

Authors

Satoshi Kimura¹, Hayato Yamaguchi¹, Yusuke Shikama², Hidetsugu Tateno², Masaya Kawaguchi¹, Kazuhiko Kotani³, Teresita Menini⁴, Alejandro Gugliucci⁴

Affiliations

¹ Department of Laboratory Medicine, Showa University Northern Yokohama Hospital, Yokohama, Japan.
² Division of Respiratory Disease, Showa University Fujigaoka Hospital, Yokohama, Japan.
³ Department of Clinical Laboratory Medicine, Jichi Medical University, Tochigi, Japan.
⁴ Glycation, Oxidation and Disease Laboratory, Touro University-California, Vallejo, CA, USA.

PMID: 29874191
DOI: 10.1515/cclm-2018-0150

No abstract available

Keywords: biomarker; colorimetric assay; hypoxia; ischemia modified albumin; respiratory disease.

Publication types

Letter

MeSH terms

Biomarkers / blood
Chronic Disease
Female
Humans
Hypoxia / blood*
Male
Middle Aged
Pilot Projects
Pulmonary Disease, Chronic Obstructive / blood*
Serum Albumin, Human

Substances

Biomarkers
ischemia-modified albumin
Serum Albumin, Human